Tech Track 100

ClinTec does clinical research for pharmaceutical and biotech companies, including Pfizer and Glaxo Smith Kline. Its current projects include research on how fasting affects diabetic patients, and how the spine responds to surgery. The Glasgow company has offices in 40 countries and recently opened one in New York. In August it raised £8m from Elephant Capital to fund expansion in India. President and chief executive Rabinder Buttar founded the company in 1997 and oversaw sales growth of 70% a year from £2.3m in 2006 to £11.4m in 2009.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyClinTec International
ActivityClinical researcher
Average 3 year sales growth70.14%
Latest sales £000s11,379

If applicable:

* supplied by company † annualised figure